Oktreotid
Octreotide is a synthetic octapeptide that pharmacologically mimics natural somatostatin, with greater potency in inhibiting growth hormone, glucagon, and insulin. It primarily binds to somatostatin receptors SSTR2 and SSTR5 and was first synthesized in 1979.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 83150-76-9
Octreotide acetate
active pharmaceutical ingredient
Acetyl-Octreotide
somatostatin analogue peptide
O-Acetyl Octreotide
synthetic somatostatin analog active
Octreotide Impurity 38
research impurity reference standard
Astragaloside A
active pharmaceutical ingredient
Elagolix sodium
gonadotropin-releasing hormone antagonist
Ofloxacin
active pharmaceutical ingredient
Desethylamiodarone
Active pharmaceutical metabolite
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
DEQANNDTNATYII-OULOTJBUSA-N
C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O